Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
The Lancet. Neurology|February 10, 2015
Clinical and imaging assessment of cognitive dysfunction in multiple sclerosisMaria A Rocca, Maria P Amato, Nicola De Stefano, et al.
BMJ Open|April 12, 2014
Reduced magnetisation transfer ratio in cognitively impaired patients at the very early stage of multiple sclerosis: a prospective, multicenter, cross-sectional studyJ H Faiss, D Dähne, K Baum, et al.
European Journal of Neurology|September 13, 2017
Characterization of social cognition impairment in multiple sclerosisM Neuhaus, S Bagutti, Ö Yaldizli, et al.
Journal of Neurology|June 20, 2012
Evaluation of a new approach for semi-automatic segmentation of the cerebellum in patients with multiple sclerosisKatrin Weier, Andreas Beck, Stefano Magon, et al.
Multiple Sclerosis and Related Disorders|September 5, 2022
Hypogammaglobulinemia: A contributing factor to multiple sclerosis fatigue?L Diem, M E Evangelopoulos, D Karathanassis, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 23, 2011
Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)D W Langdon, M P Amato, J Boringa, et al.
European Journal of Neurology|December 25, 2015
The association between olfactory bulb volume, cognitive dysfunction, physical disability and depression in multiple sclerosisÖ Yaldizli, I-K Penner, T Yonekawa, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Secreted GPNMB enhances uptake of fibrillar alpha-synuclein in a non-cell-autonomous process that can be blocked by anti-GPNMB antibodiesMarc Carceles-Cordon, Eliza M Brody, Masen L Boucher, et al.
Neuron|May 13, 2026
Secreted GPNMB enhances uptake of fibrillar alpha-synuclein in a non-cell-autonomous process that can be blocked by anti-GPNMB antibodiesMarc Carceles-Cordon, Eliza M Brody, Masen L Boucher, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 19, 2007
The Faces Symbol Test, a newly developed screening instrument to assess cognitive decline related to multiple sclerosis: first results of the Berlin Multi-Centre FST Validation StudyP Scherer, I K Penner, A Rohr, et al.
Pageof 5